Stockscreener 앱 받기
27.20
6.41%
1.625
전일 마감가:
$25.57
열려 있는:
$26.01
하루 거래량:
357.65K
Relative Volume:
0.10
시가총액:
$2.18B
수익:
-
순이익/손실:
$-96.66M
주가수익비율:
-12.65
EPS:
-2.15
순현금흐름:
$-83.73M
1주 성능:
+7.63%
1개월 성능:
+2.36%
6개월 성능:
+445.26%
1년 성능:
+373.19%
1일 변동 폭
$25.79
$27.59
1주일 범위
$23.85
$27.59
52주 변동 폭
$2.86
$36.26
올레마 Stock (OLMA) Company Profile
명칭
Olema Pharmaceuticals Inc
전화
(415) 651-3316
주소
780 BRANNAN STREET, SAN FRANCISCO
OLMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
27.20 | 2.05B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.94 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.00 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.04 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.10 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
올레마 Stock (OLMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-08 | 개시 | Guggenheim | Buy |
| 2025-08-12 | 재확인 | Citigroup | Buy |
| 2024-04-02 | 개시 | Goldman | Buy |
| 2024-01-30 | 개시 | Citigroup | Buy |
| 2023-07-21 | 개시 | Oppenheimer | Outperform |
| 2023-05-05 | 개시 | CapitalOne | Overweight |
| 2023-02-22 | 개시 | Credit Suisse | Outperform |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-06-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 개시 | H.C. Wainwright | Neutral |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2020-12-14 | 개시 | Canaccord Genuity | Buy |
| 2020-12-14 | 개시 | Cowen | Outperform |
| 2020-12-14 | 개시 | JP Morgan | Overweight |
| 2020-12-14 | 개시 | Jefferies | Buy |
모두보기
올레마 주식(OLMA)의 최신 뉴스
Olema Pharmaceuticals (NASDAQ:OLMA) Raised to Strong-Buy at UBS Group - MarketBeat
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors - Yahoo Finance
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 8.6%Here's What Happened - MarketBeat
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN
Will Olema Pharmaceuticals Inc. stock pay special dividendsGDP Growth & Expert Verified Stock Movement Alerts - ulpravda.ru
UBS Initiates Coverage on Olema Pharmaceuticals (OLMA) with a 'B - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated by Analysts at Piper Sandler - MarketBeat
Piper Sandler initiates Olema Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Canada
UBS initiates Olema Pharmaceuticals stock with Buy rating, $45 target By Investing.com - Investing.com Canada
Olema Oncology (OLMA) Targeted for Growth with $60 Price Objecti - GuruFocus
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm
Olema Oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Olema Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 2,881 Shares of Stock - MarketBeat
Olema Pharmaceuticals director Harmon sells $82,194 in stock By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals director Harmon sells $82,194 in stock - Investing.com India
Olema Pharmaceuticals Earnings Notes - Trefis
Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open - ts2.tech
Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday - ts2.tech
Will Olema Pharmaceuticals’ (OLMA) Index Debut Quietly Redefine Its Standing Among Biotech Investors? - simplywall.st
Olema: 'Strong Buy' Maintained On OPERA-02 Trial Initiation & Additional Shots On Goal - Seeking Alpha
Olema Pharmaceuticals Insider Sold Shares Worth $1,553,544, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,873,109, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,530,148, According to a Recent SEC Filing - marketscreener.com
Olema pharma chief medical officer sells shares for $7.5m By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells $7,872,504.00 in Stock - MarketBeat
Naseem Zojwalla Sells 100,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
David Myles Sells 51,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
Olema Pharmaceuticals ch. discov. Myles C. sells $1.55m in stock - Investing.com Australia
Olema pharma director Clark sells $7.87 million in shares - Investing.com India
Olema pharma director Clark sells $7.87 million in shares By Investing.com - Investing.com UK
Olema pharma chief medical officer sells shares for $7.5m - Investing.com
Olema Pharmaceuticals (OLMA): Reassessing Valuation After S&P Biotechnology Select Industry Index Inclusion - Sahm
6 people charged in $41M insider trading scheme tied to 2 biotechs - Fierce Biotech
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - MSN
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Olema Pharmaceuticals (OLMA) price target increased by 25.00% to 46.54 - MSN
How Olema Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 AllTime Highs & Short-Term Trading Opportunity Alerts - Улправда
Aug Rallies: Will Olema Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Gainers & Precise Swing Trade Entry Alerts - Улправда
Why Olema Pharmaceuticals Inc. stock is favored by pension fundsJuly 2025 Closing Moves & Verified Momentum Stock Watchlist - Улправда
Why Olema Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Intraday Action & Stock Portfolio Risk Control - Улправда
Officer Myles Files To Sell 51,000 Of Olema Pharmaceuticals Inc [OLMA] - TradingView — Track All Markets
Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025 - ts2.tech
Is Olema Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Trade Report & Detailed Earnings Play Strategies - DonanımHaber
올레마 (OLMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.25%
자본화:
|
볼륨(24시간):